Soleus Capital Management’s InspireMD NSPR Stock Holding History

Soleus Capital Management’s Portfolio NSPR Stock Details NSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.7M	Sell	1,045,708 -104,292	-9%	-$178K	0.07%	78
2025 Q4	$2.05M	Sell	1,150,000 -320,934	-22%	-$669K	0.08%	79
2025 Q3	$3.54M	Sell	1,470,934 -415,273	-22%	-$1.01M	0.18%	66
2025 Q2	$4.28M	Buy	1,886,207 +940,831	+100%	+$2.34M	0.28%	56
2025 Q1	$2.54M	Sell	945,376 -432,752	-31%	-$1.22M	0.18%	60
2024 Q4	$3.62M	Hold	1,378,128	–	–	0.23%	58
2024 Q3	$3.69M	Hold	1,378,128	–	–	0.29%	68
2024 Q2	$3.44M	Hold	1,378,128	–	–	0.3%	69
2024 Q1	$3.27M	Hold	1,378,128	–	–	0.24%	69
2023 Q4	$3.87M	Hold	1,378,128	–	–	0.43%	48
2023 Q3	$4.51M	Hold	1,378,128	–	–	0.42%	58
2023 Q2	$3.46M	Buy	+1,378,128	New	+$2.19M	0.38%	59

Other funds holding NSPR

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return

Soleus Capital Management's NSPR Position: Q1 2026 in Review

Soleus Capital Management reduced its InspireMD (NSPR) stake by 9.1% in Q1 2026, selling an estimated $178K and leaving 1,045,708 shares worth $1.7M. The position accounts for 0.07% of the portfolio, ranked #78.

Soleus Capital Management first reported a position in NSPR in Q2 2023 and has held it in 12 quarters since. The position peaked at $4.51M in Q3 2023. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

Soleus Capital Management held 1,045,708 shares of InspireMD worth $1.7M as of Q1 2026.
Soleus Capital Management sold 104,292 InspireMD shares in Q1 2026, an estimated $178K.
InspireMD made up 0.07% of Soleus Capital Management's portfolio in Q1 2026, its #78 holding.
Soleus Capital Management first reported a position in InspireMD in Q2 2023 and has held it in 12 quarters since.
Soleus Capital Management's InspireMD position peaked at $4.51M in Q3 2023.
35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Soleus Capital Management's 13F filing for Q1 2026, filed 14 May 2026.